Pooja Khatri, Heidi Sucharew, Russell P Sawyer, Vivek Khandwala, Lily Li-Li Wang, Rebecca Cornelius, Mary Gaskill-Shipley, Thomas A Tomsick, David Wang, Shantala Gangatirkar, Brady Jamal Williamson, Thomas Maloney, Paul Horn, Janice Carrozzella, Kathleen Alwell, Mary Haverbusch, Brett M Kissela, Achala Vagal
{"title":"Assessing Population-Based Radiological Brain Health in Stroke Epidemiology (APRISE): Rationale and Design.","authors":"Pooja Khatri, Heidi Sucharew, Russell P Sawyer, Vivek Khandwala, Lily Li-Li Wang, Rebecca Cornelius, Mary Gaskill-Shipley, Thomas A Tomsick, David Wang, Shantala Gangatirkar, Brady Jamal Williamson, Thomas Maloney, Paul Horn, Janice Carrozzella, Kathleen Alwell, Mary Haverbusch, Brett M Kissela, Achala Vagal","doi":"10.1159/000543431","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Approximately 20% of strokes in the United States are preceded by either a stroke or transient ischemic attack (TIA). Determining which stroke patients are at higher risk for recurrence allows for individualized, aggressive secondary stroke prevention. A comprehensive clinical decision tool, considering the full spectrum of radiological brain health\" including small vessel disease parameters, is currently lacking. Furthermore, large-scale characterization of pre-existing radiological brain health may elucidate novel phenotypes. This study aims (1) to characterize imaging manifestations of brain health at a population level, and associated demographic and clinical risk factors at the time of index stroke and (2) to create a 90-day and three-year prediction models of cerebrovascular disease recurrence (ischemic or hemorrhagic stroke) incorporating comprehensive parameters from routine clinical imaging.</p><p><strong>Methods: </strong>Our overall cohort was estimated to consist of 4250 patients hospitalized with stroke, including 525 with hemorrhagic and 3725 with ischemic/TIA subtypes, ascertained in the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS) population of 1.4 million residents from January 1, 2015 through December 31, 2015. Among 3725 ischemic stroke/TIA patients, based on published and ongoing data collection, we estimated that approximately 16% will have a recurrent ischemic or hemorrhagic stroke over the subsequent three years. Among these, 80% were estimated to have MR imaging for review. Leveraging extensive clinical and demographic data already collected in the 2015 NIH-funded GCKNSS study, we will have obtained and centrally characterized magnetic resonance imaging (MRI), acute CT, and vascular data in patients with hospitalized stroke/TIAs. We will determine if and how pre-existing imaging parameters cluster using factor analysis, and identify associated demographic and clinical risk factors in multivariable modeling. We will develop short term (90-day) and long term (three-year) risk prediction models using the machine learning approach of random survival forest with internal validation, and perform Cox regression models as a sensitivity analysis.</p><p><strong>Conclusion: </strong>The primary outcome is recurrence defined as any stroke (ischemic or hemorrhagic) occurring after index ischemic stroke or TIA event. For index ischemic strokes, the second event must within a different vascular territory if <14 days from the index event.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-15"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000543431","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Approximately 20% of strokes in the United States are preceded by either a stroke or transient ischemic attack (TIA). Determining which stroke patients are at higher risk for recurrence allows for individualized, aggressive secondary stroke prevention. A comprehensive clinical decision tool, considering the full spectrum of radiological brain health" including small vessel disease parameters, is currently lacking. Furthermore, large-scale characterization of pre-existing radiological brain health may elucidate novel phenotypes. This study aims (1) to characterize imaging manifestations of brain health at a population level, and associated demographic and clinical risk factors at the time of index stroke and (2) to create a 90-day and three-year prediction models of cerebrovascular disease recurrence (ischemic or hemorrhagic stroke) incorporating comprehensive parameters from routine clinical imaging.
Methods: Our overall cohort was estimated to consist of 4250 patients hospitalized with stroke, including 525 with hemorrhagic and 3725 with ischemic/TIA subtypes, ascertained in the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS) population of 1.4 million residents from January 1, 2015 through December 31, 2015. Among 3725 ischemic stroke/TIA patients, based on published and ongoing data collection, we estimated that approximately 16% will have a recurrent ischemic or hemorrhagic stroke over the subsequent three years. Among these, 80% were estimated to have MR imaging for review. Leveraging extensive clinical and demographic data already collected in the 2015 NIH-funded GCKNSS study, we will have obtained and centrally characterized magnetic resonance imaging (MRI), acute CT, and vascular data in patients with hospitalized stroke/TIAs. We will determine if and how pre-existing imaging parameters cluster using factor analysis, and identify associated demographic and clinical risk factors in multivariable modeling. We will develop short term (90-day) and long term (three-year) risk prediction models using the machine learning approach of random survival forest with internal validation, and perform Cox regression models as a sensitivity analysis.
Conclusion: The primary outcome is recurrence defined as any stroke (ischemic or hemorrhagic) occurring after index ischemic stroke or TIA event. For index ischemic strokes, the second event must within a different vascular territory if <14 days from the index event.
期刊介绍:
A rapidly-growing field, stroke and cerebrovascular research is unique in that it involves a variety of specialties such as neurology, internal medicine, surgery, radiology, epidemiology, cardiology, hematology, psychology and rehabilitation. ''Cerebrovascular Diseases'' is an international forum which meets the growing need for sophisticated, up-to-date scientific information on clinical data, diagnostic testing, and therapeutic issues, dealing with all aspects of stroke and cerebrovascular diseases. It contains original contributions, reviews of selected topics and clinical investigative studies, recent meeting reports and work-in-progress as well as discussions on controversial issues. All aspects related to clinical advances are considered, while purely experimental work appears if directly relevant to clinical issues.